Literature DB >> 20170392

Peyote and mescaline exposures: a 12-year review of a statewide poison center database.

Shaun D Carstairs1, F Lee Cantrell.   

Abstract

BACKGROUND: Peyote, a cactus containing the hallucinogen mescaline, has been used by Native Americans for thousands of years. Illicit use is also known to occur, but reports in the medical literature consist only of isolated case reports.
OBJECTIVES: We sought to identify characteristics of patients with reported exposure to peyote or mescaline.
METHODS: We performed a retrospective review of the California Poison Control System database for the years 1997-2008 for all cases of single-substance human exposure using the search terms "peyote" and "mescaline."
RESULTS: There were a total of 31 single-substance exposures to peyote or mescaline. Thirty (97%) exposures were intentional; 30 (97%) exposures were through the oral route, whereas one patient (3%) insufflated mescaline powder. Five patients (16%) were managed at home, whereas the remainder patients were managed in a healthcare facility. Commonly reported effects included hallucinations, tachycardia, agitation, and mydriasis. Vomiting was reported in only one case.
CONCLUSIONS: Although uncommonly encountered, use of peyote and mescaline was associated with clinically significant effects requiring treatment in a substantial number of patients. Clinical effects were usually mild or moderate, and life-threatening toxicity was not reported in this case series.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170392     DOI: 10.3109/15563650903586745

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  6 in total

Review 1.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 2.  Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Authors:  Ricardo Jorge Dinis-Oliveira; Carolina Lança Pereira; Diana Dias da Silva
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 3.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 4.  When good times go bad: managing 'legal high' complications in the emergency department.

Authors:  Charles R Caffrey; Patrick M Lank
Journal:  Open Access Emerg Med       Date:  2017-12-20

Review 5.  Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Authors:  Krista M Lisdahl; Kenneth J Sher; Kevin P Conway; Raul Gonzalez; Sarah W Feldstein Ewing; Sara Jo Nixon; Susan Tapert; Hauke Bartsch; Rita Z Goldstein; Mary Heitzeg
Journal:  Dev Cogn Neurosci       Date:  2018-02-21       Impact factor: 5.811

6.  The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Authors:  Malin Vedøy Uthaug; Alan K Davis; Trevor Forrest Haas; Dawn Davis; Sean B Dolan; Rafael Lancelotta; Christopher Timmermann; Johannes G Ramaekers
Journal:  J Psychopharmacol       Date:  2021-05-05       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.